HomeAI · summaries
Storia in 2 fonti
Teva saddles up as stalking horse bidder for bankrupt BioXcel’s neuroscience portfolio
BioXcel Therapeutics has filed for bankruptcy and lined up a deal for T | BioXcel Therapeutics has filed for bankruptcy and lined up a deal for Teva Pharmaceutical to acquire its assets for $57.5 million upfront.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
fiercebiotech.com
Teva saddles up as stalking horse bidder for bankrupt BioXcel’s neuroscience portfolio
BioXcel Therapeutics has filed for bankruptcy and lined up a deal for T | BioXcel Therapeutics has filed for bankruptcy and lined up a deal for Teva Pharmaceutical to acquire its…
- ·
benzinga.com
BioXcel Stock Plunges: Chapter 11 Filing Triggers Teva Stalking Horse Bid - Teva Pharmaceutical Indus (NY
BioXcel Chapter 11 sends BTAI shares sharply lower as Teva becomes the stalking horse bidder for IGALMI and BXCL501 assets.